News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Awakn Life Sciences Expands Commercial Operations into the U.S. - First Licensing Partnership Agreement with Revitalist
Awakn Life Sciences
Revitalist Lifestyle and Wellness
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
ATAI Life Sciences
atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital
ATAI Life Sciences
Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study
Small Pharma
Psychedelic Weekly Headlines | August 12th
Optimi Health
Lobe Sciences
PsyBio Therapeutics
Field Trip Health
Irwin Naturals
MindMed Strengthens Board with Appointment of Two New Independent Directors
Mind Medicine (MindMed)
Wellbeing Digital Sciences Inc. Changes Year-End
Wellbeing Digital Sciences
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
Mind Medicine (MindMed)
Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing
Field Trip Health
PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support Previously Submitted Provisional Biosynthetic Production Patent Application
PsyBio Therapeutics
MYND Life Sciences Announces Stock Option Grant
No items found.
Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients
Optimi Health
Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia
Lobe Sciences
Blackhawk Growth Sets AGM Date and Provides Corporate Update
MindBio Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.